DrugPatentWatch Database Preview
Patent: 6,586,238
Summary for Patent: 6,586,238
| Title: | Enzymatic nucleic acids containing 5\'-and or 3\'-cap structures |
| Abstract: | An enzymatic nucleic acid molecule comprising a 5\'- and/or a 3\'-cap structure, wherein said structure is not a 5\'-5\'-linked inverted nucleotide or a 3\'-3\'-linked inverted nucleotide. |
| Inventor(s): | Matulic-Adamic; Jasenka (Boulder, CO), Beigelman; Leonid (Longmont, CO), Karpeisky; Alexander (Boulder, CO), Jarvis; Thale (Boulder, CO), Usman; Nassim (Boulder, CO), DiRenzo; Anthony (Boulder, CO), Wincott; Francine (Longmont, CO) |
| Assignee: | Ribozyme Pharmaceuticals, Inc. (Boulder, CO) |
| Application Number: | 09/419,125 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,586,238
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | Ribozyme Pharmaceuticals, Inc. (Boulder, CO) | 2016-04-16 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | Ribozyme Pharmaceuticals, Inc. (Boulder, CO) | 2016-04-16 | RX | search | |
| Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | Ribozyme Pharmaceuticals, Inc. (Boulder, CO) | 2016-04-16 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
